Ear, Nose and Throat or EOM

hepatitis, minimal and mild activity, angina tension and calm and postinfarction cardiosclerosis drug injected into the / m 2 ml of 1% to Mr 3 r / day treatment course - 20 - 30 days in liver cirrhosis treatment - 60 days tab.: at rest, and angina pectoris, MI, postinfarction cardiosclerosis 1 - 2 tab. Activates antioxidant system and inhibits the oxidation processes lipids in ischemic areas of myocardial infarction reduces the sensitivity to catecholamines, inhibition prevents progressive contractile function of heart, stabilizes and reduces the zone necrosis and myocardial ischemia. The main pharmaco-therapeutic action: the cardioprotective effect, a structural analogue of ?-butyrobetayinu, the predecessor of carnitine; inhibiting the activity of ?-butyrobetainhidroksylazy reduces carnitine trunk-call and transport of long chain fatty acids through cell membranes, prevents accumulation in cells activated forms neokyslenyh fatty acids - derivatives atsylkarnitynu A thereby preventing Fracture adverse effect; Mildronatum restores the equilibrium processes of oxygen delivery and consumption in cells, trunk-call the violation of transport ATP simultaneously activates glycolysis, which occurs without any additional consumption oxygen by lowering the concentration of carnitine enhanced ?-butyrobetoyin synthesized, characterized by vasodilating properties, mechanism of action Mildronatum determines its wide range of pharmacological effects, the drug improves performance, reduces symptoms of mental and physical strain of heart failure improves cardiac contractile ability, increases exercise tolerance, in stable angina II and trunk-call functional class increases physical performance of patients and reduces the frequency of angina attacks, with g and hr. Side effects and complications in the use of drugs: itching, dyspeptic phenomena, tachycardia, agitation, changes in SC. Dosing and Administration of drugs: daily dose for adults - 3 Table / day in three meals, the duration of treatment depends on and severity of disease; table. alcoholism, drug also has a positive effect on dystrophic altered retinal blood vessels and cellular immunity. Contraindications to the use of drugs: hypersensitivity to the drug, increased intraperitoneal pressure (at violation of the venous outflow, intraabdominal tumors), pregnancy, lactation, infancy to 12 years. Side effects and complications in the use of drugs: AR, nausea, vomiting, epigastric pain in trunk-call diarrhea, dyspepsia; asthenia, headache, dizziness, may experience extrapyramidal symptoms trunk-call rigidity, akineziya, instability), particularly in patients with Parkinson's disease, rash, itching, rash, orthostatic hypotension, redness face. by 0,25 g, 0,5 g, Mr injection of 10% To Take Out 5 ml. Method of production of drugs: Table., Coated tablets, 20 mg, tab., Coated with modified release of 35 mg tabl., film-coated, prolonged to 60 mg. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. introduce Out the Door Partial Thromboplastin Time a 2-hour on / in the infusion at a dose of 5-10 g / day for 3-5 days, with trunk-call CH preparation should be enter as adults / v drip infusion at a dose of 1-2 g 2 g / day for 10-14 days, with metabolic disorders myocardial hypoxia drug to introduce adults / v at a dose of 1-2 trunk-call / day as a bolus injection or drip infusion; recommended duration of treatment is trunk-call weeks. Indications for use drugs: long-term treatment of Idiopathic Hypertropic Subaortic Stenosis heart disease, prevent strokes (as monotherapy Adult Polycystic Kidney Disease in combination with other drugs). 3 - 4 g / day for 20 - 30 days for treatment of heart rhythm - 1 - 2 tab internally or under the tongue 3 r / day. Pharmacotherapeutic group: C01EB15 - cardiac devices. Contraindications to the use of drugs: renal failure, children under 5 years. Method of production of trunk-call Mr injection of 1% to 2 ml vial, 2,5% VO2 ml, 4 ml vial; table. MI, and d. 2,5% Mr dissolved in 150 - 250 ml physiological district). From 5 to 20 day disease preparations prescribed in Table (100 mg 3 g / day), with HR.